Apply on Employer Site

Kymera Therapeutics · 19 hours ago

Business Development MBA Intern

Greater Boston

Internship

Onsite

Intern

$45/hr - $55/hr

Kymera Therapeutics is a clinical-stage biotechnology company pioneering the field of targeted protein degradation to develop innovative medicines. The Business Development MBA Intern will support the business development team in market research, competitive analysis, and strategic evaluations to identify potential partnership opportunities.

BiotechnologyHealth CareMedicalTherapeutics

Growth Opportunities

Responsibilities

Embed with the business development team on critical issues related to partnering strategy and transaction related workstreams

Conduct market research and competitive analysis to identify emerging trends, unmet needs, and potential opportunities in therapeutic areas of strategic interest

Support target prioritization and evaluation, including high-level screening of potential partners, technologies, or assets

Assist in due diligence, including data gathering, synthesis, and creation of briefing materials for internal stakeholders

Prepare presentations and summaries for business development discussions, internal strategy forums, and leadership reviews

Collaborate with cross-functional teams (e.g., Research, Clinical, Legal, Finance) to support elements of strategic analysis and partnership assessment

Contribute to special projects that may include financial modeling, valuation support, and development of strategic recommendations

Qualification

Analytical skillsResearch skillsProblem-solving skillsBiotech interestLife sciences experienceMicrosoft OfficeCommunication skills

Required

Currently enrolled in a top MBA program (rising 2nd-year) with a strong academic record

Demonstrated interest in biotech, and life sciences

Prior experience in life sciences consulting, investment banking, or business development

Exceptional analytical, research, and problem-solving skills

Strong written and verbal communication skills; ability to synthesize complex information clearly

Comfortable working both independently and collaboratively in a fast-paced environment

Proficiency with Microsoft Office (Excel, PowerPoint)

Ability to be onsite in Watertown, Ma June - August 2026 (start/end dates are flexible)

Company

Kymera Therapeutics

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Founded in 2017

Cambridge, Massachusetts, USA

51-200 employees

http://www.kymeratx.com/

Funding

Current Stage

Public Company

Total Funding

$1.96B

Key Investors

Biotechnology Value FundAtlas Venture

2025-12-10Post Ipo Equity· $602M

2025-06-26Post Ipo Equity· $250.8M

2024-08-19Post Ipo Equity· $225M

Leadership Team

Nello Mainolfi

Founder, President and Chief Executive Officer

Jeremy Chadwick

Chief Operating Officer

Recent News

Yahoo Finance

Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside

2026-01-16

GlobeNewswire

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

2026-01-14

Labiotech UG

The biggest biotech funding rounds in December 2025

2026-01-11

Company data provided by crunchbase